Search Results - "Gravenfors, Ylva"
-
1
Rapid Construction of a Chloromethyl-Substituted Duocarmycin-like Prodrug
Published in Molecules (Basel, Switzerland) (16-06-2023)“…The construction of duocarmycin-like compounds is often associated with lengthy synthetic routes. Presented herein is the development of a short and convenient…”
Get full text
Journal Article -
2
Ultralarge Virtual Screening Identifies SARS-CoV‑2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Published in Journal of the American Chemical Society (23-02-2022)“…Drugs targeting SARS-CoV-2 could have saved millions of lives during the COVID-19 pandemic, and it is now crucial to develop inhibitors of coronavirus…”
Get full text
Journal Article -
3
New Aminoimidazoles as β‑Secretase (BACE-1) Inhibitors Showing Amyloid‑β (Aβ) Lowering in Brain
Published in Journal of medicinal chemistry (08-11-2012)“…Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and…”
Get full text
Journal Article -
4
Core Refinement toward Permeable β‑Secretase (BACE-1) Inhibitors with Low hERG Activity
Published in Journal of medicinal chemistry (13-06-2013)“…By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic…”
Get full text
Journal Article -
5
The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features
Published in Journal of medicinal chemistry (22-09-2016)“…Glioblastoma remains an incurable brain cancer. Drugs developed in the past 20 years have not improved the prognosis for patients, necessitating the…”
Get full text
Journal Article -
6
Discovery of novel pyrrolopyridazine scaffolds as transient receptor potential vanilloid (TRPV1) antagonists
Published in Bioorganic & medicinal chemistry letters (15-11-2012)“…A novel indolizine class of compounds was identified as TRPV1 antagonist from an HTS campaign. However, this indolizine class proved to be unstable and reacted…”
Get full text
Journal Article -
7
Creation of Novel Cores for β‑Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy
Published in ACS medicinal chemistry letters (10-04-2014)“…In order to find optimal core structures as starting points for lead optimization, a multiparameter lead generation workflow was designed with the goal of…”
Get full text
Journal Article -
8
Phenyl isoxazole voltage-gated sodium channel blockers: Structure and activity relationship
Published in Bioorganic & medicinal chemistry letters (01-07-2011)“…Blocking of certain sodium channels is considered to be an attractive mechanism to treat chronic pain conditions. Phenyl isoxazole carbamate 1 was identified…”
Get full text
Journal Article -
9
Correction to New Aminoimidazoles as β‑Secretase (BACE-1) Inhibitors Showing Amyloid‑β (Aβ) Lowering in Brain
Published in Journal of medicinal chemistry (26-11-2012)Get full text
Journal Article -
10
Exploring the specificity of small molecules exhibiting anti-Abeta aggregating activity
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
11
P2‐226: Exploring the specificity of small molecules exhibiting anti‐Abeta aggregating activity
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article